Pharmacogenetics of genes across the doxorubicin pathway. - Wikidata - wikimedia - TriplyDB

Pharmacogenetics of genes across the doxorubicin pathway.

Pharmacogenetics of genes across the doxorubicin pathway.

http://www.wikidata.org/entity/Q37932556

about

Overview of high throughput sequencing technologies to elucidate molecular pathways in cardiovascular diseases Chemotherapy-related toxicity in patients with non-metastatic Ewing sarcoma: influence of sex and age.Rho protein GTPases and their interactions with NFκB: crossroads of inflammation and matrix biology Fitness profiling links topoisomerase II regulation of centromeric integrity to doxorubicin resistance in fission yeast Metabolism of doxorubicin to the cardiotoxic metabolite doxorubicinol is increased in a mouse model of chronic glutathione deficiency: A potential role for carbonyl reductase 3.Endoplasmic reticulum protein 29 (ERp29) confers radioresistance through the DNA repair gene, O(6)-methylguanine DNA-methyltransferase, in breast cancer cells A novel derivative of doxorubicin, AD198, inhibits canine transitional cell carcinoma and osteosarcoma cells in vitro Drug-induced oxidative stress and toxicity.Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia.Pharmacogenetics of anthracyclines.Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.Protective effects of onion (Allium cepa) extract against doxorubicin-induced hepatotoxicity in rats.

P2860

Q26859589-724E02B0-5C63-4162-95DB-5C2F6674C668 Q33410703-563EB0EA-C9D9-42E7-AFF8-F4CDAA281393 Q33802112-0539193F-0E9E-4418-9B67-C00384D600CB Q35070152-84F605A1-89E7-4324-858D-2C3FB56D1356 Q35553905-8D713442-4D3F-428C-A150-887AC1FF8D2E Q36106739-92F2DE8D-5E19-4351-87A6-1DFFF9312D4E Q36110948-0DDF13E0-83DE-49F3-BCB3-45EB7028A38E Q38037517-208F1199-55F7-43EF-ADD6-FFF113AA4FE1 Q38063197-0B37F622-BF7D-4EAE-B2C8-5BAB0A440A97 Q38856218-2AA57488-3BD6-44A1-BD69-9128015B0849 Q42573841-362257E2-2CD0-4215-8442-8D3396B14301 Q44309602-5ACDE436-B6E7-4251-B5C8-4494801D1492

P2860

Pharmacogenetics of genes across the doxorubicin pathway.

http://www.wikidata.org/entity/Q37932556

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacogenetics of genes across the doxorubicin pathway.

@en

Pharmacogenetics of genes across the doxorubicin pathway.

@nl

type

label

Pharmacogenetics of genes across the doxorubicin pathway.

@en

Pharmacogenetics of genes across the doxorubicin pathway.

@nl

prefLabel

Pharmacogenetics of genes across the doxorubicin pathway.

@en

Pharmacogenetics of genes across the doxorubicin pathway.

@nl

P1433

Q37932556-A3B05D17-D465-4AB6-87B7-16D824026D1C

P1476

Q37932556-96D14F05-11F7-4805-8C96-8E88162D3CE2

P2093

Q37932556-141A430A-B639-4B76-9AA3-B3188934008E

Q37932556-73AA9538-67C2-4694-BAB9-4826FD394419

P2860

Q37932556-07906025-65CE-4F81-B2B4-1C5D568547AB

Q37932556-08D20D67-A19E-4A4D-A6F0-8809BB8C6FF0

Q37932556-0EA1F099-D495-48AE-A360-5B7A4643DA2C

Q37932556-1645D128-0262-41A6-A09B-C4FF97685AC5

Q37932556-1DA64F6D-9035-4926-9AD6-33496FD47BCF

Q37932556-1E943C5A-6FD7-46A0-A13C-3D0A9D19ABB4

Q37932556-2278D970-1807-45CD-A789-19C6103107EA

Q37932556-27AE9AA2-B089-48D5-B1B9-D3C146344518

Q37932556-287290AC-3CE0-437D-9585-51FFA43AB560

Q37932556-2EBABE2A-5FBA-4313-908D-B09732C8A799

P304

Q37932556-61D1EA2E-EBB7-4979-A685-8F81F3B125B6

P31

Q37932556-59CA40F0-A506-415C-A9C2-230CC5234960

P356

Q37932556-F0A42B74-0DE9-4571-A5AF-85F1D3DF695F

P407

Q37932556-BC00D3E6-ADF2-495B-B491-81810EDE5EBF

P433

Q37932556-08B1074F-3BC0-4BFD-AEAB-3160B590147A

P478

Q37932556-3E15A3F7-45C1-4D23-9949-7ACB1D7F365A

P50

Q37932556-359BCA59-891D-43B1-9D12-C48C7C73F513

Q37932556-A91B6585-8E07-4AD3-A4F8-5930B7962602

P577

Q37932556-4FF9F1E2-D2B6-43F3-853C-CA7E66E6D9CB

P698

Q37932556-C5CA320C-BBE8-4853-8CF8-3E30B7815D04

P356

17425255.2011.610180

P1433

Expert Opinion on Drug Metabolism & Toxicology

P1476

Pharmacogenetics of genes across the doxorubicin pathway

@en

P2093

Alan V Boddy

http://www.w3.org/2001/XMLSchema#string

David Jamieson

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

Naturally occurring variants of human aldo-keto reductases with reduced in vitro metabolism of daunorubicin and doxorubicin

Characterization of the organic cation transporter SLC22A16: a doxorubicin importer

A distinct "side population" of cells with high drug efflux capacity in human tumor cells

Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donors

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

Function-altering SNPs in the human multidrug transporter gene ABCB1 identified using a Saccharomyces-based assay

Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo

A "silent" polymorphism in the MDR1 gene changes substrate specificity

Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIalpha.

P304

1201-1210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17425255.2011.610180

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21919804

http://www.w3.org/2001/XMLSchema#string